Neoadjuvant Talazoparib in Patients With Germline BRCA1/2 Mutation-Positive, Early-Stage Triple-Negative Breast Cancer: Results of a Phase II Study.
The oncologist（2023）
摘要
NCT03499353.
更多查看译文
关键词
poly(ADP-ribose) polymerase inhibitors, triple-negative breast neoplasms, neoadjuvant therapy, antineoplastic agents
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要